Citigroup’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Hold |
0
| – | – | – | 5638 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 5325 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 5181 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 5199 |
|
2020
Q1 | – | Sell |
-5
| Closed | – | – | 5256 |
|
2019
Q4 | $0 | Sell |
5
-594
| -99% | – | ﹤0.01% | 5246 |
|
2019
Q3 | $4K | Sell |
599
-952
| -61% | -$6.36K | ﹤0.01% | 4863 |
|
2019
Q2 | $9K | Sell |
1,551
-3,449
| -69% | -$20K | ﹤0.01% | 4784 |
|
2019
Q1 | $53K | Buy |
5,000
+2,796
| +127% | +$29.6K | ﹤0.01% | 3990 |
|
2018
Q4 | $18K | Buy |
2,204
+441
| +25% | +$3.6K | ﹤0.01% | 4458 |
|
2018
Q3 | $34K | Sell |
1,763
-150
| -8% | -$2.89K | ﹤0.01% | 4309 |
|
2018
Q2 | $35K | Sell |
1,913
-14,883
| -89% | -$272K | ﹤0.01% | 4097 |
|
2018
Q1 | $178K | Buy |
16,796
+9,976
| +146% | +$106K | ﹤0.01% | 3008 |
|
2017
Q4 | $287K | Sell |
6,820
-8,684
| -56% | -$365K | ﹤0.01% | 2749 |
|
2017
Q3 | $854K | Sell |
15,504
-12,282
| -44% | -$677K | ﹤0.01% | 2045 |
|
2017
Q2 | $5.16M | Buy |
27,786
+27,763
| +120,709% | +$5.15M | ﹤0.01% | 937 |
|
2017
Q1 | $3K | Sell |
23
-1,666
| -99% | -$217K | ﹤0.01% | 4606 |
|
2016
Q4 | $168K | Buy |
1,689
+1,418
| +523% | +$141K | ﹤0.01% | 3674 |
|
2016
Q3 | $30K | Sell |
271
-57
| -17% | -$6.31K | ﹤0.01% | 3988 |
|
2016
Q2 | $34K | Sell |
328
-1,135
| -78% | -$118K | ﹤0.01% | 3898 |
|
2016
Q1 | $134K | Buy |
1,463
+929
| +174% | +$85.1K | ﹤0.01% | 3779 |
|
2015
Q4 | $77K | Buy |
+534
| New | +$77K | ﹤0.01% | 3774 |
|
2015
Q3 | – | Hold |
0
| – | – | – | 5644 |
|